ITCI

Intra-Cellular Therapies, Inc.

1 day chart

About ITCI

Intra-Cellular Therapies, Inc. is a biopharmaceutical company. The Company is focused on the discovery, clinical development and commercialization of small molecule drugs that address underserved medical needs primarily in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system (CNS). The Company’s product CAPLYTA is a treatment for depressive episodes associated with bipolar I or II disorder (bipolar depression) in adults as monotherapy and as adjunctive therapy with lithium or valproate. The efficacy of CAPLYTA 42 mg in bipolar depression was demonstrated in two positive Phase III placebo-controlled bipolar depression studies, which evaluated the effects of CAPLYTA on depression in adult patients with bipolar I or bipolar II disorder both as monotherapy (Study 404) and as adjunctive therapy with lithium or valproate (Study 402).

Buy US stocks in Australia starting with ITCI. Open an account and start investing today!

Market Capitalisation

$5.42B

Price-earnings ratio

Dividend yield

0.00%

Volume

1.02M

High today

$56.54

Low today

$54.52

Open price

$56.50

52-week high

$67.05

52-week low

$42.01

ITCI FAQs

Can I buy ITCI shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?

Yes, the Stake platform allows you to buy ITCI shares and over 8,000 stocks and ETFs across the ASX and Wall St.

How much is one share of Intra-Cellular Therapies, Inc.?

One share of Intra-Cellular Therapies, Inc. is valued at $55.71.

What is the ticker symbol for Intra-Cellular Therapies, Inc.?

The ticker symbol for Intra-Cellular Therapies, Inc. is ITCI.

How do I buy ITCI shares in Australia?

To buy ITCI stocks in Australia you'll need to open an account with an investing platform like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in ITCI

What is the 52-week high for Intra-Cellular Therapies, Inc. stock?

The Intra-Cellular Therapies, Inc. 52-week high stock price is $67.05.

What is the 52-week low for Intra-Cellular Therapies, Inc. stock?

The Intra-Cellular Therapies, Inc. 52-week low stock price is $42.01.

What is the market capitalisation of Intra-Cellular Therapies, Inc. ITCI?

As of 16/09/2023 Intra-Cellular Therapies, Inc. has a market cap of $5.4B.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.